THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., April 30, 2004 – Amgen (N), today announced that Enbrel® (etanercept) has been approved by the U.S. Food and Drug Ad ASDAQ: AMGN) and Wyeth ...

Amgen Inc. won U.S. approval Friday to market its rheumatoid arthritis drug Enbrel as a treatment for the skin disorder psoriasis. A Food and Drug Administration spokeswoman said Enbrel had been ...

THOUSAND OAKS, Calif., and COLLEGEVILLE, Pa., JUNE 19, 2003 – Amgen (NASDAQ: AMGN), the world's largest biotechnology company, and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) today announced new results from multiple studies of ENBREL, further expanding the ...

The risk of serious infection varied among biologic and targeted agents used to treat moderate-to-severe psoriasis but overall was low across the drug classes, a large retrospective review showed. As ...

SILVER SPRING, Md. - An expert advisory panel told the FDA Wednesday that it should approve Amgen Inc.'s Enbrel (etanercept) to treat moderate to severe plaque psoriasis in pediatric patients as young ...

Shares of Amgen rose modestly in pre-market trading Friday after the No. 1 biotech firm said its rheumatoid arthritis treatment Enbrel had positive results in late-stage testing on patients with the ...

On September 15, 2020, Merck Canada Inc., an affiliate of Merck & Co., Inc., announced that Health Canada approved BRENZYS® (etanercept) for the following additional indications: Adult patients with ...

WASHINGTON, June 16 (Reuters) - U.S. Food and Drug Administration reviewers are concerned about life-threatening complications in children taking Amgen Inc's drug Enbrel for psoriasis and other ...

In real-world settings, new initiators of targeted therapies for psoriatic arthritis experienced a low incidence of serious infection, with a lower risk observed among those starting etanercept and ...

If you’re looking at treatment options for certain kinds of psoriasis or arthritis, you may want to learn more about Enbrel (etanercept). The active ingredient in Enbrel is etanercept. An active ...